Abstract
Obstructive Sleep Apnoea – Hypopnea Syndrome (OSAHS) is a potentially serious sleep disorder in which breathing repeatedly stops and starts during sleep. It is associated with significant co-morbidities affecting millions of people around the world. Many of these individuals remain undiagnosed while those who are diagnosed often exhibit poor compliance with the nightly use of Continuous Positive Air Pressure (CPAP), a very effective non-invasive modality. The growing failure and discomfort reported by the patients brought light into the possibility of other options such as oral appliance therapy and surgical therapy, with an absolute cure rate in moderate to severe OSAHS seen with Maxillo-Mandibular Advancement (MMA) surgery. The article reviews various Oral and Maxillofacial management options for the treatment of OSAHS with their success rates.
| Original language | English |
|---|---|
| Pages (from-to) | 840-844 |
| Number of pages | 5 |
| Journal | Journal of Pharmaceutical Sciences and Research |
| Volume | 9 |
| Issue number | 6 |
| Publication status | Published - 01-01-2017 |
All Science Journal Classification (ASJC) codes
- Pharmaceutical Science
Fingerprint
Dive into the research topics of 'Oral and maxillofacial approach for the treatment of obstructive sleep Apnea - Review'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver